FDA Approved: SUMATRIPTAN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for Sumatriptan succinate from Aurobindo Pharma Limited under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sumatriptan succinate (Sumatriptan succinate)

Snippet

SUPPL AP for SUMATRIPTAN (SUMATRIPTAN SUCCINATE)